LSE:AZNPharmaceuticals
AstraZeneca (LSE:AZN) Extends Pipeline Optimism, Is The Stock Still Undervalued?
AstraZeneca (LSE:AZN) stock is back in focus after a recent period of mixed short term returns, with the shares up 1.8% over the past day but nearly flat over the past 3 months.
See our latest analysis for AstraZeneca.
The recent 7 day share price return of 8.19% has added to year to date share price gains of 5.34%, while a 1 year total shareholder return of 42.48% points to stronger longer term momentum in AstraZeneca stock.
If AstraZeneca's recent move has you thinking about where growth...